Evidence map›Paper›PMID 36361031›Full record

ArticleInternational journal of environmental research and public health2022

Mandibular Torus as a New Index of Success for Mandibular Advancement Devices.

Teresa Diaz de Teran, Pedro Muñoz, Felix de Carlos, Emilio Macias, Marta Cabello, Olga Cantalejo, Paolo Banfi, Antonello Nicolini, Paolo Solidoro, Monica Gonzalez

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Teresa Diaz de TeranSleep and Ventilation Unit, Pneumology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Pedro MuñozCantabria Primary Health Care Management, Instituto Marqués de Valdecilla (IDIVAL), 39011 Santander, Spain.ORCID 0000-0002-1387-2655
Felix de CarlosDepartment of Surgery and Medical-Surgical Specialties, Area of Orthodontics, Faculty of Medicine, University of Oviedo, 33003 Oviedo, Spain.
Emilio MaciasDepartment of Surgery and Medical-Surgical Specialties, Area of Orthodontics, Faculty of Medicine, University of Oviedo, 33003 Oviedo, Spain.
Marta CabelloSleep and Ventilation Unit, Pneumology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Olga CantalejoSleep and Ventilation Unit, Pneumology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Paolo BanfiDon Gnocchi Foundation IRCCS, 20121 Milan, Italy.ORCID 0000-0001-8162-0751
Antonello NicoliniDon Gnocchi Foundation IRCCS, 20121 Milan, Italy.ORCID 0000-0001-8286-7406
Paolo SolidoroDivision of Respiratory Diseases Cardiovascular and Thoracic Department, AOU Città della Salute e della Scienza di Torino, 10126 Torino, Italy.
Monica GonzalezSleep and Ventilation Unit, Pneumology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Marqués de Valdecilla University Hospital · ESDon Carlo Gnocchi Foundation · ITUniversidad de Oviedo · ESAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITInstituto de Investigación Marqués de Valdecilla · ESUniversidad de Cantabria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn obstructive sleep apnoea (OSA), treatment with mandibular advancement devices (MADs) reduces patients' Apnoea-Hypopnoea index (AHI) scores and improves their sleepiness and quality of life. MADs are non-invasive alternatives for patients who cannot tolerate traditional continuous positive airway pressure (CPAP) therapy. The variability of responses to these devices makes it necessary to search for predictors of success. The aim of our study was to evaluate the presence of mandibular torus as a predictor of MAD efficacy in OSA and to identify other potential cephalometric factors that could influence the response to treatment.

methodsThis was a retrospective cohort study. The study included 103 patients diagnosed of OSA who met the criteria for initiation of treatment with MAD. Structural variables were collected (cephalometric and the presence or absence of mandibular torus). Statistical analysis was performed to evaluate the existence of predictive factors for the efficacy of MADs.

resultsA total of 103 patients who were consecutively referred for treatment with MAD were included (89.3% men); the mean age of the participants was 46.3 years, and the mean AHI before MAD was 31.4 (SD 16.2) and post- MAD 11.3 (SD 9.2). Thirty-three percent of patients had mandibular torus. Torus was associated with a better response (odds ratio (OR) = 2.854 (

conclusionsThe presence of a mandibular torus practically triples the probability of MAD success. This is the simplest examination with the greatest benefits in terms of the efficacy of MAD treatment for OSA.

Indexed as

Mandibular AdvancementSleep Apnea, ObstructiveFemaleHumansMaleMiddle AgedOcclusal SplintsQuality of LifeRetrospective StudiesTreatment Outcomecephalometrymandibular advancement devicesmandibular torusobstructive sleep apnoea

Identifiers

PMID36361031
PMCPMC9657412
OpenAlexW4308124617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.